Approach to Acute Cardiovascular Complications in COVID-19 Infection
Lauren S. Ranard, J. Fried, Marwah Abdalla, D. Edmund Anstey, Raymond C. Givens, Deepa Kumaraiah, Susheel Kodali, Koji Takeda, Dimitrios Karmpaliotis, LeRoy E. Rabbani, Gabriel Sayer, Ajay J. Kirtane, Martin B. Leon, Allan Schwartz, Nir Uriel, Amirali Masoumi
Abstract
The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic with primary respiratory manifestations in those who are symptomatic. It has spread to >187 countries with a rapidly growing number of affected patients. Underlying cardiovascular disease is associated with more severe manifestations of COVID-19 and higher rates of mortality. COVID-19 can have both primary (arrhythmias, myocardial infarction, and myocarditis) and secondary (myocardial injury/biomarker elevation and heart failure) cardiac involvement. In severe cases, profound circulatory failure can result. This review discusses the presentation and management of patients with severe cardiac complications of COVID-19 disease, with an emphasis on a Heart-Lung team approach in patient management. Furthermore, it focuses on the use of and indications for acute mechanical circulatory support in cardiogenic and/or mixed shock.